REGISTRAT-MAPI

About:

REGISTRAT-MAPI, Inc. is a clinical research organization focusing on late phase studies for biopharmaceutical and medical device companies

Website: http://www.registratmapi.com/

Description:

REGISTRAT-MAPI, Inc. is a clinical research organization focusing on late phase studies for biopharmaceutical and medical device companies globally. It offers consulting services in the areas of late phase study design, epidemiology, risk management planning, and regulatory strategy and interactions; and services for the design and conduct of late phase studies, including prospective and retrospective studies. The company also provides services, such as study operational support, risk management and safety, direct-to-patient contact management, ethical and personal data protection, multi-national observational studies, country-specific studies. REGISTRAT-MAPI, Inc. was formerly known as REGISTRAT, Inc. The company was incorporated in 1997 and is based in Lexington, Kentucky with additional offices in North America, Europe, and Asia. REGISTRAT-MAPI has locations in Lyon and Paris, France; Frankfurt am Main, Germany; London, United Kingdom; Lexington, Kentucky; and Philadelphia and Berwyn, Pennsylvania. As of June 15, 2009, REGISTRAT-MAPI, Inc. operates as a subsidiary of MAPI Developpement, SAS.

Total Funding Amount:

$1.5M

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

Lexington, Kentucky, United States

Founded Date:

1997-01-01

Founders:

Bernard Jambon

Number of Employees:

501-1000

Last Funding Date:

2009-06-15

IPO Status:

Private

Industries:

© 2025 bioDAO.ai